{"id":690,"date":"2021-09-07T14:49:13","date_gmt":"2021-09-07T14:49:13","guid":{"rendered":"http:\/\/events.marketsandmarkets.com\/blog\/?p=690"},"modified":"2021-09-07T14:55:35","modified_gmt":"2021-09-07T14:55:35","slug":"ning-wang-talks-about-single-cell-sequencing-a-powerful-approach-to-profile-tumor-microenvironment-at-advance-genetic-sequencing-virtual-conference-2021","status":"publish","type":"post","link":"https:\/\/events.marketsandmarkets.com\/blognew\/ning-wang-talks-about-single-cell-sequencing-a-powerful-approach-to-profile-tumor-microenvironment-at-advance-genetic-sequencing-virtual-conference-2021\/","title":{"rendered":"Ning Wang talks about \u201cSingle cell sequencing: a powerful approach to profile tumor microenvironment\u201d at Advance Genetic Sequencing Virtual Conference 2021"},"content":{"rendered":"\n

Ning is a bioinformatics scientist at Arcus\nBiosciences, where he is responsible for drug discovery, target identification,\nand indication prioritization in multiple immune-oncology drug programs.\nNotably, Ning pioneered the 3D organoids based drug response prediction\ntechnology, which largely facilitated cancer model selection. During his PhD,\nhe studied with Professor Alexander Hoffmann at UCLA, where he built up computational\nframework to identify synergy between key immune response signaling pathways in\nmacrophage. Ning holds a PhD in Bioinformatics from UCLA.<\/p>\n\n\n\n

Marketsandmarkets took this opportunity to pick his brains on the newfound developments in the fields of genetic sequencing and the ways this research has been of paramount importance in overcoming the challenges of the pandemic. He also discusses her own learnings in the field, their presentation at the Conference their take on the conference program.\u00a0\u00a0 <\/p>\n\n\n\n

Question: <\/strong>What are the recent\nadvances in the genetic sequencing field and current challenges that need\nimmediate attention?<\/strong><\/p>\n\n\n\n

Ning :<\/strong><\/strong><\/p>\n\n\n\n

Genetic sequencing is a very broad and active\nfield. One of the recent advances is combining multiple single cell sequencing\nmodalities including genomics, transcriptomics and epigenetics to study tumor\nheterogeneity and tumor microenvironment from patients under therapeutic\ntreatment. One of the challenges is how to accurately infer single cell\ngenotype from single cell RNA-seq data in clinical samples<\/p>\n\n\n\n

Question: <\/strong>What\nis the key take away point from your presentation topic which will help in\nbuilding the knowledge base of attendees? \n<\/strong><\/p>\n\n\n\n

Ning:<\/strong><\/strong><\/p>\n\n\n\n